Global Breast Cancer Screening Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

Breast cancer screening is the medical screening of asymptomatic, apparently healthy women for breast cancer in an attempt to achieve an earlier diagnosis.

A number of screening tests have been employed, including clinical and self-breast exams, mammography, genetic screening, ultrasound, and magnetic resonance imaging.

According to APO Research, The global Breast Cancer Screening market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Breast Cancer Screening is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Breast Cancer Screening is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Breast Cancer Screening is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Breast Cancer Screening is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Breast Cancer Screening include Hologic, GE Healthcare, Siemen Healthineers, Philips Healthcare, Canon Medical, Fujifilm, Metaltronica, Sino Medical-Device and IMS Srl, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Breast Cancer Screening, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Breast Cancer Screening, also provides the sales of main regions and countries. Of the upcoming market potential for Breast Cancer Screening, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Breast Cancer Screening sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Breast Cancer Screening market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Breast Cancer Screening sales, projected growth trends, production technology, application and end-user industry.


Breast Cancer Screening Segment by Company

Hologic
GE Healthcare
Siemen Healthineers
Philips Healthcare
Canon Medical
Fujifilm
Metaltronica
Sino Medical-Device
IMS Srl

Breast Cancer Screening Segment by Type

Mammography Screening
Breast Magnetic Resonance Imaging (MRI) Screening
Breast Ultrasound Screening

Breast Cancer Screening Segment by Application

Hospital
Clinic

Breast Cancer Screening Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Breast Cancer Screening market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Breast Cancer Screening and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Breast Cancer Screening.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Breast Cancer Screening market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Breast Cancer Screening manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Breast Cancer Screening in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Breast Cancer Screening in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Breast Cancer Screening Market Size, 2020 VS 2024 VS 2031
1.3 Global Breast Cancer Screening Market Size Estimates and Forecasts (2020-2031)
1.4 Global Breast Cancer Screening Sales Estimates and Forecasts (2020-2031)
1.5 Global Breast Cancer Screening Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Breast Cancer Screening Market Dynamics
2.1 Breast Cancer Screening Industry Trends
2.2 Breast Cancer Screening Industry Drivers
2.3 Breast Cancer Screening Industry Opportunities and Challenges
2.4 Breast Cancer Screening Industry Restraints
3 Breast Cancer Screening Market by Manufacturers
3.1 Global Breast Cancer Screening Revenue by Manufacturers (2020-2025)
3.2 Global Breast Cancer Screening Sales by Manufacturers (2020-2025)
3.3 Global Breast Cancer Screening Average Sales Price by Manufacturers (2020-2025)
3.4 Global Breast Cancer Screening Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Breast Cancer Screening Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Breast Cancer Screening Manufacturers, Product Type & Application
3.7 Global Breast Cancer Screening Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Breast Cancer Screening Market CR5 and HHI
3.8.2 Global Top 5 and 10 Breast Cancer Screening Players Market Share by Revenue in 2024
3.8.3 2024 Breast Cancer Screening Tier 1, Tier 2, and Tier 3
4 Breast Cancer Screening Market by Type
4.1 Breast Cancer Screening Type Introduction
4.1.1 Mammography Screening
4.1.2 Breast Magnetic Resonance Imaging (MRI) Screening
4.1.3 Breast Ultrasound Screening
4.2 Global Breast Cancer Screening Sales by Type
4.2.1 Global Breast Cancer Screening Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Breast Cancer Screening Sales by Type (2020-2031)
4.2.3 Global Breast Cancer Screening Sales Market Share by Type (2020-2031)
4.3 Global Breast Cancer Screening Revenue by Type
4.3.1 Global Breast Cancer Screening Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Breast Cancer Screening Revenue by Type (2020-2031)
4.3.3 Global Breast Cancer Screening Revenue Market Share by Type (2020-2031)
5 Breast Cancer Screening Market by Application
5.1 Breast Cancer Screening Application Introduction
5.1.1 Hospital
5.1.2 Clinic
5.2 Global Breast Cancer Screening Sales by Application
5.2.1 Global Breast Cancer Screening Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Breast Cancer Screening Sales by Application (2020-2031)
5.2.3 Global Breast Cancer Screening Sales Market Share by Application (2020-2031)
5.3 Global Breast Cancer Screening Revenue by Application
5.3.1 Global Breast Cancer Screening Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Breast Cancer Screening Revenue by Application (2020-2031)
5.3.3 Global Breast Cancer Screening Revenue Market Share by Application (2020-2031)
6 Global Breast Cancer Screening Sales by Region
6.1 Global Breast Cancer Screening Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Breast Cancer Screening Sales by Region (2020-2031)
6.2.1 Global Breast Cancer Screening Sales by Region (2020-2025)
6.2.2 Global Breast Cancer Screening Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Breast Cancer Screening Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Breast Cancer Screening Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Breast Cancer Screening Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Breast Cancer Screening Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Breast Cancer Screening Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Breast Cancer Screening Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Breast Cancer Screening Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Breast Cancer Screening Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Breast Cancer Screening Revenue by Region
7.1 Global Breast Cancer Screening Revenue by Region
7.1.1 Global Breast Cancer Screening Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Breast Cancer Screening Revenue by Region (2020-2025)
7.1.3 Global Breast Cancer Screening Revenue by Region (2026-2031)
7.1.4 Global Breast Cancer Screening Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Breast Cancer Screening Revenue (2020-2031)
7.2.2 North America Breast Cancer Screening Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Breast Cancer Screening Revenue (2020-2031)
7.3.2 Europe Breast Cancer Screening Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Breast Cancer Screening Revenue (2020-2031)
7.4.2 Asia-Pacific Breast Cancer Screening Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Breast Cancer Screening Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Breast Cancer Screening Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Hologic
8.1.1 Hologic Comapny Information
8.1.2 Hologic Business Overview
8.1.3 Hologic Breast Cancer Screening Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Hologic Breast Cancer Screening Product Portfolio
8.1.5 Hologic Recent Developments
8.2 GE Healthcare
8.2.1 GE Healthcare Comapny Information
8.2.2 GE Healthcare Business Overview
8.2.3 GE Healthcare Breast Cancer Screening Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 GE Healthcare Breast Cancer Screening Product Portfolio
8.2.5 GE Healthcare Recent Developments
8.3 Siemen Healthineers
8.3.1 Siemen Healthineers Comapny Information
8.3.2 Siemen Healthineers Business Overview
8.3.3 Siemen Healthineers Breast Cancer Screening Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Siemen Healthineers Breast Cancer Screening Product Portfolio
8.3.5 Siemen Healthineers Recent Developments
8.4 Philips Healthcare
8.4.1 Philips Healthcare Comapny Information
8.4.2 Philips Healthcare Business Overview
8.4.3 Philips Healthcare Breast Cancer Screening Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Philips Healthcare Breast Cancer Screening Product Portfolio
8.4.5 Philips Healthcare Recent Developments
8.5 Canon Medical
8.5.1 Canon Medical Comapny Information
8.5.2 Canon Medical Business Overview
8.5.3 Canon Medical Breast Cancer Screening Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Canon Medical Breast Cancer Screening Product Portfolio
8.5.5 Canon Medical Recent Developments
8.6 Fujifilm
8.6.1 Fujifilm Comapny Information
8.6.2 Fujifilm Business Overview
8.6.3 Fujifilm Breast Cancer Screening Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Fujifilm Breast Cancer Screening Product Portfolio
8.6.5 Fujifilm Recent Developments
8.7 Metaltronica
8.7.1 Metaltronica Comapny Information
8.7.2 Metaltronica Business Overview
8.7.3 Metaltronica Breast Cancer Screening Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Metaltronica Breast Cancer Screening Product Portfolio
8.7.5 Metaltronica Recent Developments
8.8 Sino Medical-Device
8.8.1 Sino Medical-Device Comapny Information
8.8.2 Sino Medical-Device Business Overview
8.8.3 Sino Medical-Device Breast Cancer Screening Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Sino Medical-Device Breast Cancer Screening Product Portfolio
8.8.5 Sino Medical-Device Recent Developments
8.9 IMS Srl
8.9.1 IMS Srl Comapny Information
8.9.2 IMS Srl Business Overview
8.9.3 IMS Srl Breast Cancer Screening Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 IMS Srl Breast Cancer Screening Product Portfolio
8.9.5 IMS Srl Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Breast Cancer Screening Value Chain Analysis
9.1.1 Breast Cancer Screening Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Breast Cancer Screening Production Mode & Process
9.2 Breast Cancer Screening Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Breast Cancer Screening Distributors
9.2.3 Breast Cancer Screening Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings